Breaking News: Investing
Bitcoin retail investor at ‘max desperation,’ says Bitwise CIO, but crypto winter not coming
Crypto World Bitcoin retail investor at ‘max desperation,’ says Bitwise CIO, but crypto winter not coming Published Tue, Nov 4 20257:07 PM ESTUpdated 13 Min Ago Krysta Escobar WATCH LIVE Source
Read More
Goldman’s Nachmann warns of ‘deployment pressure’ from explosion of evergreen funds
A version of this article appeared in CNBC’s Inside Alts newsletter, a guide to the fast-growing world of alternative investments, from private equity and private credit to hedge funds and venture capital. Sign up to receive future editions, straight to your inbox. Wealthy individuals have been pouring into alternative assets in recent years, thanks in part to […]
Read More
Warren Buffett may have cut Berkshire’s stake in Apple again in the third quarter
Warren Buffett speaks during the Berkshire Hathaway Annual Shareholders Meeting in Omaha, Nebraska on May 3, 2025. CNBC Warren Buffett’s Berkshire Hathaway may have quietly trimmed its massive Apple stake again in the third quarter, a new regulatory filing suggests. In its latest quarterly report, Berkshire said the cost basis of its consumer products equity […]
Read More
Berkshire posts solid earnings. But Wall Street doubts the stock can rally with Buffett’s exit looming
Warren Buffett’s Berkshire Hathaway reported a sharp rebound in operating profit over the weekend, but Wall Street analysts were divided on the outlook for the conglomerate between optimism over its insurance rebound and succession uncertainty. The Omaha-based company said operating earnings from its collection of businesses, including insurance, railroads and energy, rose 34% from a […]
Read More
Stock futures are little changed to start November trading: Live updates
Traders work on the floor at the New York Stock Exchange on Sept. 17, 2025. Brendan McDermid | Reuters Stock futures were little changed on Sunday night, as a new month of trading begins. S&P 500 futures ticked higher by 0.1% along with Nasdaq-100 futures. Dow Jones Industrial Average futures advanced 16 points, or less […]
Read More
Evolve Bank CEO fired after propositioning FBI agent who pretended to be a teen boy
Evolve Bank CEO Bob Hartheimer booking photo. Source: Shelby County Jail Bob Hartheimer, CEO of Tennessee’s Evolve Bank & Trust, was fired after U.S. law enforcement officials caught him propositioning a law enforcement officer posing as a 15-year-old boy on gay dating app Grindr. On Oct. 19, an employee of the Federal Bureau of Investigation […]
Read More
Interest rate backdrop supports playing offense with bonds, according to Goldman Sachs former ETF head
Bonds may be more than just a safe haven. BondBloxx ETFs’ Tony Kelly, a former Goldman Sachs Asset Management global ETF head, contends it’s where investors can also play offense due to the market backdrop. “It’s definitely getting more nuanced,” the firm’s co-founder told CNBC’s “ETF Edge” this week. “Advisors are being a bit more thoughtful […]
Read More
Berkshire’s operating earnings jump 34%, Buffett buys back no stock and raises cash hoard to $381 billion
Warren Buffett and Greg Abel walkthrough the Berkshire Hathaway Annual Shareholders Meeting in Omaha, Nebraska on May 3, 2025. David A. Grogen | CNBC Warren Buffett’s Berkshire Hathaway reported a sharp rebound in operating profit on Saturday, while its cash pile swelled to a new high with no buybacks. Berkshire’s operating profit generated from the […]
Read More
Bank of America names five stocks with more room to run before they report earnings
Bank of America named several stocks that are well positioned ahead of the rest of earnings season. The Wall Street investment bank says companies like Uber are too attractive to ignore. Other buy-rated names screened by CNBC Pro include: Datadog , Doximity, RB Global and Futu. Doximity The social platform for physicians is firing on […]
Read More
Shares of breast cancer therapy developer Olema Pharmaceutical could more than double from here
Wall Street is optimistic that Olema Pharmaceutical could be developing the next major breakthrough breast cancer treatment. Earlier this month, the company announced promising clinical data for its lead candidate palazestrant, an oral medication that is being evaluated in several trials for estrogen receptor-positive, or ER+, breast cancer. Shares of the clinical-stage biopharmaceutical company are up […]
Read More